Dysregulation of TGF-β signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease
Authors:
- 15 June 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (12) , 5601-5609
Abstract
We previously demonstrated that CD4+CD25+ T regulatory cells (Tregs), important for the maintenance of immune tolerance and prevention of autoimmune disease, from patients with human T lymphotropic virus type I (HTLV-I)–associated myelopathy/tropical spastic paraparesis (HAM/TSP) exhibit reduced Foxp3 expression and Treg suppressor function compared with healthy donors. Since TGF-β signaling has been previously reported to be critical for both Foxp3 expression and Treg function, we examined whether this signaling pathway was dysregulated in patients with HAM/TSP. Levels of TGF-β receptor II (TGF-βRII) as well as Smad7 (a TGF-β–inducible gene) were significantly reduced in CD4+ T cells in patients with HAM/TSP compared with healthy donors, and the expression of TGF-βRII inversely correlated with the HTLV-I tax proviral load. Importantly, both CD4+CD25+ and CD4+CD25− T cells from HAM/TSP patients exhibited reduced TGF-βRII expression compared with healthy donors, which was associated with functional deficits in vitro, including a block in TGF-β–inducible Foxp3 expression that inversely correlated with the HTLV-I tax proviral load, loss of Treg suppressor function, and escape of effector T cells from Treg-mediated control. This evidence suggests that a virus-induced breakdown of immune tolerance affecting both regulatory and effector T cells contributes to the pathogenesis of HAM/TSP.Keywords
This publication has 62 references indexed in Scilit:
- Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-β-dependent mechanismProceedings of the National Academy of Sciences, 2008
- Induction of FOXP3 expression in naive human CD4+FOXP3− T cells by T-cell receptor stimulation is transforming growth factor-β–dependent but does not confer a regulatory phenotypeBlood, 2007
- Smad7 Antagonizes Transforming Growth Factor β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex FormationMolecular and Cellular Biology, 2007
- Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathologyJournal of Clinical Investigation, 2006
- TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cellsJournal of Experimental Medicine, 2005
- Transforming growth factor-β in T-cell biologyNature Reviews Immunology, 2002
- Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytesAnnals of Neurology, 1996
- Differential Effect of TGF-β1 on the in Vitro Activation of HTLV-I and the Proliferative Response of CD8+ T Lymphocytes in Patients with HTLV-I-Associated Myelopathy (HAM/TSP)Clinical Immunology and Immunopathology, 1995
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISThe Lancet, 1985